ISRCTN11239735
进行中（未招募）
未知
Research on new treatment methods for neurogenic gastrointestinal diseases based on neuroendocrine axis and artificial intelligence technology
Chifeng Cancer Hospital0 个研究点目标入组 100 人2024年3月5日
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- Preventing psychological illness in patients with neurogastroenteropathy
- 发起方
- Chifeng Cancer Hospital
- 入组人数
- 100
- 状态
- 进行中（未招募）
- 最后更新
- 2年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •1\. Free from genetic diseases
- •2\. Patients with neural digestive disease, with no mental illness
- •3\. Patients with IBS\-D
排除标准
- •Diseases with obvious abnormalities in the auditory system
结局指标
主要结局
未指定
相似试验
招募中
不适用
Development of treatment for neurological dysfunction using Brain-machine interface based on MEG and EEGeurological dysfunctionJPRN-UMIN000010180Osaka university40
进行中（未招募）
不适用
Development of non-invasive neuromodulation treatment for depressive disorder by violet light- double-blind, randomized, crossover studyMajor depressive disorderDepressionJPRN-jRCTs032210260Kitahata Ryosuke70
已完成
不适用
Study for new treatment methods and classifications of severity based on lymph function in patients with lymphedemalymphedemaJPRN-UMIN000009146Yokohama City University Hospital100
已完成
不适用
Study for new treatment methods and classifications of severity based on lymph function in patients with primary lymphedemaprimary lymphedemaJPRN-UMIN000004772Yokohama City University Hospital70
招募中
不适用
Investigating brain mechanisms and new treatment modalities for persistent postural-perceptual dizziness (PPPD)Diseases of the nervous systemKCT0005068The Catholic University of Korea, Incheon St. Mary's Hospital60